Semaglutide Weekly Injection Active Ingredient in Ozempic and Wegovy 15% Body Weight Reduction GLP-1 Receptor Agonist FDA Approved for Type 2 Diabetes (2017) and Weight Loss (2021) Most Common Side Effects: Nausea, Diarrhea, Vomiting, Constipation, Indigestion, and Abdominal Pain Tirzepatide Weekly Injection Active Ingredient in Mounjaro 20% Body Weight reduction Dual GLP-1 and GIP Receptor Agonist FDA Approved for Type 2 Diabetes (2022) and on Fast-track for Weight Loss Approval in 2023 Most Common Side Effects: Nausea, Diarrhea, Vomiting, Constipation, Indigestion, and Abdominal Pain These injections are GLP-1 medications that have been FDA-approved for Type 2 diabetes because of their ability to lower blood sugar and raise insulin levels
Semaglutide vs Liraglutide: The Basics While both medications mimic the GLP-1 hormone, they are manufactured differently, prescribed under different brand names, and administered on different schedules
We are committed to providing cost-effective solutions, offering competitive pricing that ensures weight loss injections are affordable and within reach for the community
Also learn how often adverse effects are reported when taking workout and bodybuilding supplements, weight loss supplements, and more
Compared with traditional peptide APIs, GLP-1 programs introduce several new operational pressures
